drugset / Trial / NCT06271096

Intramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children

NCT06271096

Phase 0 Completed 150 enrolled Arooj Khan
RandomizedParallel-groupOpen-labelTreatment

Summary

IM-midazolam in acute seizures, whenever IV cannulation is not possible. It is easy to administer and can be used in prehospital settings as IV cannulation requires experience, especially in pediatric age group. Moreover, the transit time to the hospital can be prolonged in our areas which can delay the treatment if intravenous cannulation is considered. More studies are required to assess the feasibility of administering IM-midazolam in a prehospital setting to control acute seizures

Timeline

Start
2019-11-01
Primary completion
2022-11-01
Completion
2024-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule 0.2 mg/kg Intravenous
Subject Midazolam Small molecule 0.2 mg/kg Intramuscular

Indications